ANACONDA BIOMED, S.L.

Anaconda Biomed, S.L. specializes in neurovascular access devices. Specifically, they develop products like the ANA5 Advanced Neurovascular Access and the ANA Advanced Neurovascular Access, which are designed to assist in endovascular procedures—interventions performed inside blood vessels, often for treating neurological conditions.

The company is headquartered in Barcelona, Spain. This location reflects its focus on developing innovative medical technologies tailored to global endovascular healthcare needs.

Anaconda Biomed, S.L.’s devices are listed in the eudamed database, which is the official European Union registry for medical devices. This inclusion ensures transparency and compliance with EU regulatory requirements.

The company’s neurovascular access devices, including the ANA5 and ANA models, fall under Class III classification in the EU. This classification applies to high-risk devices that require stringent regulatory oversight due to their critical role in patient safety and clinical outcomes.